Beverages containing Lactobacillus paracasei LC-37 improved functional dyspepsia through regulation of the intestinal microbiota and their metabolites
- 1 June 2021
- journal article
- research article
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 104 (6) , 6389-6398
Abstract
Functional dyspepsia (FD) is a common disease of the digestive system and probiotics have been reported to be effective in the treatment of functional gastrointestinal diseases. The aim of this study was to determine the effect of the beverage containing Lactobacillus paracasei LC-37 (LC-37) and its ability to relieve symptoms of FD by a randomized clinical trial. Due to the mechanistic complexity underlying FD, intestinal microbiota and stool metabolomes were also evaluated. The results showed that FD was relieved in participants after treatment with the beverage containing LC-37 for 14 and 28 d. The clinical symptom scores were significantly decreased after these times (abdominal pain and belching were significantly decreased after 14 d and almost absent after 28 d of treatment). Probiotics, such as those containing the Lactobacillus, Lactococcus, and Weissella, significantly increased, and the abundance of harmful bacteria such as Lachnocliostridium significantly decreased. Furthermore, relevant beneficial intestinal metabolites such as pelargonic acid, benzoic acid, and short-chain fatty acids increased, and harmful intestinal metabolites such as hippuric acid decreased. Taken together, these findings suggested that the beverages containing LC-37 can increase the abundance of probiotics and decrease pathogenic bacteria, and thereby improve beneficial intestinal metabolites. Therefore, the beverages containing LC-37 may provide a natural alternative to combat FD.Keywords
This publication has 29 references indexed in Scilit:
- Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generationNature, 2013
- Functional dyspepsia: the economic impact to patientsAlimentary Pharmacology & Therapeutics, 2013
- Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsiaGut, 2013
- Functional dyspepsia—symptoms, definitions and validity of the Rome III criteriaNature Reviews Gastroenterology & Hepatology, 2013
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR AntagonistCell Metabolism, 2013
- Anti-obesity effect of kimchi fermented withWeissella koreensisOK1-6 as starter in high-fat diet-induced obese C57BL/6J miceJournal of Applied Microbiology, 2012
- Intracellular lipid accumulation inhibitory effect of Weissella koreensis OK1-6 isolated from Kimchi on differentiating adipocyteJournal of Applied Microbiology, 2012
- Probiotic Bacteria Induce Maturation of Intestinal Claudin 3 Expression and Barrier FunctionThe American Journal of Pathology, 2012
- The effect of probiotics on gastric mucosal permeability in humans administered with aspirinScandinavian Journal of Gastroenterology, 2011
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeabilityGut, 2009